首页> 美国卫生研究院文献>Annals of Medicine and Surgery >A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown – Retrospective cohort study
【2h】

A simplified primary aldosteronism surgical outcome score is a useful prediction model when target organ damage is unknown – Retrospective cohort study

机译:简化的主要醛固酮在靶器官损伤未知 - 回顾队列研究时是一种有用的预测模型 - 回顾性队列研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Cure of hypertension after adrenalectomy for primary aldosteronism is no certainty and therefore preoperative patient counseling is essential. The Primary Aldosteronism Surgical Outcome (PASO) Score is a useful prediction model with an area under the curve (AUC) of 0.839. The PASO Score includes ‘Target Organ Damage’ (TOD) (i.e., left ventricular hypertrophy and/or microalbuminuria), which is often unavailable during preoperative counseling and might therefore limit its use in clinical practice. We hypothesized that the PASO score would still be useful if TOD is unknown at time of counseling. Therefore, we aimed to examine the predictive performance of the simplified PASO Score, without taking TOD into account.
机译:对原发性醛固酮肾上腺切除术后的高血压治愈尚不确定,因此术前患者咨询至关重要。原发性醛固酮症外科结果(PASO)得分是一种有用的预测模型,其曲线下的面积(AUC)为0.839。 PASO得分包括“靶器官损伤”(TOD)(即,左心室肥大和/或微蛋白尿),在术前咨询期间通常不可用,因此可能限制其在临床实践中的使用。我们假设如果TOD在咨询时未知,则Paso评分仍然有用。因此,我们旨在审查简化的PASO评分的预测性能,而不考虑到账户。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号